You are here

Pfizer Launches 2013 Integrated Annual Review

Tuesday, March 18, 2014 - 10:00am


Pfizer Inc. (NYSE:PFE) today announced the launch of its fourth integrated annual review (, which summarizes the company’s 2013 financial, environmental and social responsibility performance.

Pfizer first combined the reporting of corporate responsibility activities, financial performance, and business strategy with its 2010 annual review, and since then, has continued to advance the integrated reporting of information relevant to all of the company’s stakeholders.

Pfizer Chairman and Chief Executive Officer Ian C. Read said in his annual letter to shareholders that Pfizer had made clear progress on its mission to become the premier, innovative biopharmaceutical company. “In 2013, Pfizer achieved solid results for patients, consumers, and shareholders by maintaining our focus on developing new therapies, driving growth, and delivering value,” Mr. Read said. “Health care providers, regulators, and patients look to Pfizer to deliver medicines and vaccines that make peoples’ lives better,” he added. “By earning their trust, we also earn greater respect from society.”

In addition to summarizing the company’s financial performance, the annual review addresses the company’s progress relative to other key performance indicators, such as the number of top 20 diseases addressed by current and in-development Pfizer products, company efforts to improve access to medicines, and publicly stated targets achieved in the reduction of greenhouse gases.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Everyday, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at


Pfizer Inc.

Media Relations

Jennifer Kokell, 212-733-2596


Investor Relations

Ryan Crowe, 212-733-8160